Literature DB >> 15096311

Cardiac Effects of Stroke.

Raymond T.F. Cheung1, Vladimir Hachinski.   

Abstract

Our brain regulates all bodily functions either directly or indirectly, and cardiovascular control is no exception. There is strong clinical evidence of cerebrogenic cardiac arrhythmias and myocardial changes during ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Alternative scenarios include cardioembolic stroke, multisystem diseases with stroke-like and cardiac features, and coincidental detection of cardiac disorders in a stroke patient. Cardiac effects of stroke may be severe or even fatal and worsen the prognosis. Clinical and experimental studies suggest that cortical and subcortical structures such as the insular cortex and amygdala play a pathogenic role. The peripheral mechanisms involve abnormal sympathetic activity, altered parasympathetic activity, and raised levels of circulating catecholamines, whereas the central mechanisms are largely unknown. Because stroke patients are best managed in an acute stroke unit during their initial presentation, a cardiocerebral approach is desirable with close cardiovascular and neurologic monitoring. Prolonged and intensive cardiovascular monitoring is recommended in patients manifesting cerebrogenic cardiovascular disturbances and in high-risk patients with insular involvement, right-sided stroke, advancing age, coexisting hypertensive or coronary artery disease, or intense emotional stress. Although the best management is largely unknown, treatment of cardiac effects of stroke is largely supportive according to the type of disturbance. Severely affected patients should be evaluated by a cardiologist prior to the initiation of appropriate therapy. Much more clinical and basic research is needed to allow a full understanding of the brain-heart control, the consequences of disruption of this control, the true incidence of cardiac effects of stroke, and the evidence-based treatment options.

Entities:  

Year:  2004        PMID: 15096311     DOI: 10.1007/s11936-996-0014-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  19 in total

Review 1.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society.

Authors:  Carina Blomström-Lundqvist; Melvin M Scheinman; Etienne M Aliot; Joseph S Alpert; Hugh Calkins; A John Camm; W Barton Campbell; David E Haines; Karl H Kuck; Bruce B Lerman; D Douglas Miller; Charlie Willard Shaeffer; William G Stevenson; Gordon F Tomaselli; Elliott M Antman; Sidney C Smith; Joseph S Alpert; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Richard O Russell; Silvia G Priori; Jean Jacques Blanc; Andzrej Budaj; Enrique Fernandez Burgos; Martin Cowie; Jaap Willem Deckers; Maria Angeles Alonso Garcia; Werner W Klein; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Carlos Araujo Morais; Ali Oto; Otto Smiseth; Hans Joachim Trappe
Journal:  J Am Coll Cardiol       Date:  2003-10-15       Impact factor: 24.094

Review 2.  Cardiac rhythm disorders and muscle changes with cerebral lesions.

Authors:  Raymond T F Cheung; Vladimir Hachinski
Journal:  Adv Neurol       Date:  2003

Review 3.  Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography.

Authors:  Robert L McNamara; Leonardo J Tamariz; Jodi B Segal; Eric B Bass
Journal:  Ann Intern Med       Date:  2003-12-16       Impact factor: 25.391

4.  Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke.

Authors:  D Sander; K Winbeck; J Klingelhöfer; T Etgen; B Conrad
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

5.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

Authors:  M R Mayberg; H H Batjer; R Dacey; M Diringer; E C Haley; R C Heros; L L Sternau; J Torner; H P Adams; W Feinberg
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

Review 6.  The insula and cerebrogenic sudden death.

Authors:  R T Cheung; V Hachinski
Journal:  Arch Neurol       Date:  2000-12

7.  Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels.

Authors:  Hakan Ay; Ethem Murat Arsava; Okay Saribaş
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

8.  Autonomic nervous system function in patients with acute brainstem stroke.

Authors:  B Meglic; J Kobal; J Osredkar; T Pogacnik
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

Review 9.  Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs.

Authors:  Avi Fischer; Rajiv Verma; Joseph A Gomes; Davendra Mehta
Journal:  Mt Sinai J Med       Date:  2002-09

10.  Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction.

Authors:  D Sander; J Klingelhöfer
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

View more
  9 in total

1.  A pilot study evaluating a simple cardiac dysfunction score to predict complications and survival among critically-ill patients with traumatic brain injury.

Authors:  Patric W Gibbons; Robert J Goldberg; Susanne Muehlschlegel
Journal:  J Crit Care       Date:  2019-08-08       Impact factor: 3.425

2.  Rationale of the SEAS study: Serial Echocardiography After Subarachnoid haemorrhage, a prospective national, multicentre, multidisciplinary, cohort study to evaluate cardiac abnormalities following intracranial haemorrhage.

Authors:  I A C van der Bilt; D Hasan; G J E Rinkel; A A M Wilde; F C Visser
Journal:  Neth Heart J       Date:  2006-11       Impact factor: 2.380

Review 3.  Neurogenic stunned myocardium.

Authors:  Hoang Nguyen; Jonathan G Zaroff
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

4.  Perioperative cardiovascular changes in patients with traumatic brain injury: A prospective observational study.

Authors:  Ranganatha Praveen; Aveek Jayant; Shalvi Mahajan; Kiran Jangra; Nidhi Bidyut Panda; Vinod K Grover; Manoj K Tewari; Hemant Bhagat
Journal:  Surg Neurol Int       Date:  2021-04-19

Review 5.  Neurogenic stress cardiomyopathy: What do we need to know.

Authors:  Ramachandran Gopinath; Syama Sundar Ayya
Journal:  Ann Card Anaesth       Date:  2018 Jul-Sep

Review 6.  Hypertensive Crisis in Acute Cerebrovascular Diseases Presenting at the Emergency Department: A Narrative Review.

Authors:  Mariagiovanna Cantone; Giuseppe Lanza; Valentina Puglisi; Luisa Vinciguerra; Jaime Mandelli; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Rosella Ciurleo; Alessia Bramanti
Journal:  Brain Sci       Date:  2021-01-07

7.  The brain-heart connection: frontal cortex and left ventricle angiotensinase activities in control and captopril-treated hypertensive rats-a bilateral study.

Authors:  Ana B Segarra; Isabel Prieto; Inmaculada Banegas; Ana B Villarejo; Rosemary Wangensteen; Marc de Gasparo; Francisco Vives; Manuel Ramírez-Sánchez
Journal:  Int J Hypertens       Date:  2013-02-12       Impact factor: 2.420

8.  Incidence and outcome of cardiac injury in patients with severe head trauma.

Authors:  Ahmed Hasanin; Amr Kamal; Shereen Amin; Dina Zakaria; Riham El Sayed; Kareem Mahmoud; Ahmed Mukhtar
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-04-27       Impact factor: 2.953

9.  Myocardial ischemic changes of electrocardiogram in intracerebral hemorrhage: A case report and review of literature.

Authors:  Xue-Qi Lin; Liang-Rong Zheng
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.